#BioNTech SE is a German biotechnology company based in Mainz that develops and manufactures active immunotherapies for patient-specific approaches to the treatment of diseases.
Covid-19 vaccine maker BioNTech plans to make any malaria or tuberculosis vaccine it develops in Africa, the company said on Friday.
The announcement comes at a time when debate is growing over the moral obligation of richer countries to share Covid-19 vaccines with poorer ones—particularly the messenger RNA-based vaccines developed by BioNTech (ticker: BNTX), its partner, Pfizer (PFE), and their competitor, Moderna
Covid-19 vaccine maker BioNTech plans to make any malaria or tuberculosis vaccine it develops in Africa, the company said on Friday.
The announcement comes at a time when debate is growing over the moral obligation of richer countries to share Covid-19 vaccines with poorer ones—particularly the messenger RNA-based vaccines developed by BioNTech (ticker: BNTX), its partner, Pfizer (PFE), and their competitor, Moderna
Penafian
Maklumat dan penerbitan adalah tidak bertujuan, dan tidak membentuk, nasihat atau cadangan kewangan, pelaburan, dagangan atau jenis lain yang diberikan atau disahkan oleh TradingView. Baca lebih dalam Terma Penggunaan.
Penafian
Maklumat dan penerbitan adalah tidak bertujuan, dan tidak membentuk, nasihat atau cadangan kewangan, pelaburan, dagangan atau jenis lain yang diberikan atau disahkan oleh TradingView. Baca lebih dalam Terma Penggunaan.